|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current assets | ||||||||
| Cash | ||||||||
| Receivable from employee | ||||||||
| Prepaid expenses | ||||||||
| Reimbursement receivable | ||||||||
| Total current assets | ||||||||
| Deferred offering costs | ||||||||
| Long-term prepaid insurance | ||||||||
| Investments held in Trust Account | ||||||||
| Total Assets | ||||||||
| Liabilities and Shareholders' Deficit: | ||||||||
| Current liabilities | ||||||||
| Accrued expenses | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Accrued offering costs | ||||||||
| Promissory note - related party | ||||||||
| Advance from related party | ||||||||
| Over-allotment option liability | ||||||||
| Total current liabilities | ||||||||
| Promissory note - related party | ||||||||
| Total Liabilities | ||||||||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.67 and $10.49 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Shareholders' Deficit | ||||||||
| Ordinary shares | ||||||||
| Class A ordinary shares | ||||||||
| Class B ordinary shares | ||||||||
| Share subscription receivable | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated Deficit | ||||||||
| Total Shareholders' Deficit | ||||||||
| Total Liabilities and Shareholders' Deficit |
Loading...
